Pfizer and Moderna Analysis Re-do
“The excess risk of serious adverse events found in our study points to the need for formal harm-benefit analyses, particularly those that are stratified according to risk of serious COVID-19 outcomes such as hospitalization or death.” The headlines look pretty serious at first glance. But the discussion section should alert us that the authors are […]